Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05613257 · ClinicalTrials.gov registry record · NA

Distal Targeter vs Free-hand

A NA study, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
NA
Development phase
89
Enrollment target

NCT05613257: Completed NA study, sponsored by Cedars-Sinai Medical Center.

NCT05613257 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05613257, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
NA
Development phase
89 participants
Enrollment target

Study Summary

This study is a randomized controlled trial comparing the use of two different surgical techniques--free-hand versus distal targeting jig-based for distal interlock screw--placement and their effects on total operative time and intraoperative radiation exposure.

Primary Outcome

Number of fluoroscopic images taken intraoperatively for screw placement and cumulative radiation exposure (in grays)

Interventions

  • DEVICE Distal targeting jig
  • PROCEDURE Free-hand/perfect circles technique

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2022-10-31
Est. Completion 2024-02-01
Phase NA
Cedars-Sinai Medical Center

339 total trials

What the finished NCT05613257 record still lists

NCT05613257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Distal targeting jig is the first listed.

NCT05613257 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05613257 about?

NCT05613257 is a clinical study titled "Distal Targeter vs Free-hand". This study is a randomized controlled trial comparing the use of two different surgical techniques--free-hand versus distal targeting jig-based for distal interlock screw--placement and their effects on total operative time and intraoperative radiation exposure.

What is the current status of trial NCT05613257?

This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2022-10-31. Estimated completion is 2024-02-01.

What interventions are being tested in trial NCT05613257?

The interventions under investigation include: Distal targeting jig (DEVICE), Free-hand/perfect circles technique (PROCEDURE).

Who is sponsoring clinical trial NCT05613257?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05613257's enrollment target sits among peer trials

89 972nd of 2000 higher than 1,029 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03682289 · 89 participants · Phase 2

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

  • NCT04787939 · 89 participants · NA

    Early Feeding After Oral Cavity Reconstruction

  • NCT05480449 · 89 participants · Phase 1

    Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

  • NCT05604131 · 89 participants · Phase 2

    Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05613257, the US trial registry maintained by the National Library of Medicine. NCT05613257 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.